our operations

Existing

  • CIS - Russia, Ukraine, Latvia, Belarus, Lithuania, Kazakhstan, Georgia, Armenia, Moldova, Uzbekistan

  • Africa - SA, Kenya, Nigeria, Mauritius, Zimbabwe, Zambia, RDC, Cameroon, IVC, Tanzania, Uganda, Ethiopia, Sudan, Mozambique and Franco fone countries.

  • South-East Asia/Pacific - Sri Lanka, Thailand, Vietnam, Myanmar, Maldives, Philippines, Macau, Singapore, Maldives, Fiji, Papua New-Guinea, New Zealand, Australia, Taiwan

  • Middle East -Oman, Yemen, Bahrain, Iran, Iraq, Egypt, Syria

  • North America - USA, Canada

  • Europe - Denmark, Hungary, France Bulgaria

  • Latin America - Brazil, West Indies, Dominican Republic, Mexico

  • Far East - Japan, South Korea

Future Plans

  • Saudi Arabia

  • Angola

  • Estonia

  • Czech Republic

  • Romania

  • Slovakia

  • Slovenia

  • Bosnia

  • Croatia

  • Yugoslavia

  • Albania

  • Chile

  • Venezuela

  • Columbia

  • Paraguay

  • Hong Kong

  • China

  • Jordan

  • Lebanon

Be-TABS Pharmaceuticals (Pty) Ltd.

A joint venture agreement has been signed with Be-Tabs Pharmaceuticals (Pty) Ltd., South Africa's leading pharmaceuticals' manufacturer.

Cadila Pharmaceuticals (Nigeria) Ltd.

Cadila Pharmaceuticals' Limited Nigeria office Inter Pharma initially entered the market with pharmaceutical products and will follow it up with CPL's range of hospital disposables, veterinary medicines and other specialities in a phased manner.

Cadila Pharmaceuticals (E.A.) Ltd.


Based in Nairobi, this is the first fully-owned subsidiary of the group on foreign soil. The strategic integration will also serve a host of other countries covered under the PTA (Preferential Trade Area).

Kadera Yokuhin Ltd.

Based in Tokyo, Cadila Pharmaceuticals' marketing office in the Asian continent, the branch is a part of the marketing network for APIs.
Besides the African Continent, Cadila Pharmaceuticals exports its formulations, bulk actives, hospital disposables and veterinary formulations to over 46 countries covering CIS region, SAARC, GCC and Latin America. Cadila Pharmaceuticals' ability to win global tenders amidst stiff competition, speaks volumes about the confidence it has generated in foreign markets.